Strategic expansion InVita has been actively expanding through multiple acquisitions in 2026, including MAK-SYSTEM International Group and IT Synergistics, and launched iReferral software nationwide. This indicates a growth trajectory and an opportunity to upsell integrated end-to-end blood management solutions to newly acquired and recently onboarded clients.

End-to-end platform The company offers a broad suite of interconnected modules (HemaConnect, HemaCollect, HemaControl, HemaComply, BloodHub, BloodBill, BloodRelay) that cover scheduling, delivery, donor recruitment, compliance, and logistics. This creates opportunities to cross-sell additional modules to customers seeking comprehensive, unified blood management workflows.

Advanced therapy push Recent launches of advanced therapy capabilities and collaborations (April 2026) and iReferral across healthcare systems signal a growing focus on complex biologics and organ/tissue related workflows. This presents sales opportunities with centers expanding into advanced therapies seeking compatible software for tracking, compliance, and logistics.

Healthcare partnerships Active partnerships and deployments with large health systems and centers (e.g., Singing River Health System and Gulf Coast Blood) demonstrate market validation and a pathway to multi-site contracts. Leverage references and expand into additional facilities within partner networks.

Global and mid-market fit The combination of global expansion through MAK-SYSTEM and the presence of mid-market competitors suggests there is a scalable opportunity across regional centers and international sites seeking robust, compliant blood management platforms with strong integration capabilities and vendor interoperability.